ライフサイエンスコーパス: cancer staging

1 ation of revised American Joint Committee on Cancer staging.

2 altered upon oncogene activation and during cancer staging.

3 repeat surgery, and improve the accuracy of cancer staging.

4 icals and applications other than whole-body cancer staging.

5 an improve the prognostic accuracy of breast cancer staging.

6 h PET information, play an important role in cancer staging.

7 for multi-organ metastatic disease, and for cancer staging.

8 sion profile and American Joint Committee on Cancer staging.

9 und guidance promises great advances in lung cancer staging.

10 igh-resolution T2-weighted MRI in esophageal cancer staging.

11 ow breathing is inadequate for comprehensive cancer staging.

12 al impact of endoscopic ultrasound in rectal cancer staging.

13 vantages of including nodal ratios in breast cancer staging.

14 nning and monitoring treatment response, and cancer staging.

15 supports wider use of SLN biopsy for breast cancer staging.

16 ssion by RT-PCR may be useful for colorectal cancer staging.

17 reening approach for PSA and PSM in prostate cancer staging.

18 s an improvement in the accuracy of prostate cancer staging.

19 t common indication for the PET/CT order was cancer staging (226 cases, 75 %), with 74 % for solid an

20 to increase the sensitivity and accuracy of cancer staging and early detection of locoregional or sy

21 has become increasingly valuable for rectal cancer staging and inflammatory bowel disease but has ye

22 story, RB1 mutation status, 8th edition TNMH cancer staging and International Intraocular Retinoblast

23 Purpose Standard cancer staging and prognostic estimates are determined a

24 ing research published so far has focused on cancer staging and restaging in patients undergoing (18)

25 T combined with mostly anatomic MRI improves cancer staging and restaging.

26 ficant clinical utility by facilitating both cancer staging and treatment monitoring to more rapidly

27 tegral to patient care, forming the basis of cancer staging and treatment planning.

28 s can provide important information to guide cancer staging and treatment, and thus further research

29 opharyngeal SCC underwent PET/CT for initial cancer staging and were included in the study.

30 Coping with sampling sourced artifacts and cancer staging are among the debated topics, along with

31 gional lymph node metastases is important in cancer staging as it guides the prognosis of the patient

32 traoperative sentinel lymph node mapping for cancer staging, (b) video-angiography during surgery, an

33 The Barcelona Clinic Liver Cancer staging classification is the best at stratifying

34 Esophageal cancer staging continues to evolve, especially for advan

35 for risk assessment can improve the standard cancer staging criteria and supported the incorporation

36 as performed on 59 patients found on routine cancer staging CT scans to have unsuspected PE.

37 of patients found to have unsuspected PE on cancer staging CT scans were symptomatic.

38 Cancer staging determines extent of disease, facilitatin

39 ed using the following keywords: "esophageal cancer staging," "endoscopic ultrasound," and "endoscopi

40 yield of (18)F-FDG PET/CT for initial breast cancer staging, even in stage II patients, whatever thei

41 increase the sensitivity and specificity of cancer staging for diagnostic and prognostic purposes.

42 The current American Joint Committee on Cancer staging for PTC in patients younger than age 45 y

43 Recently, preoperative lung cancer staging has evolved to include endobronchial ultr

44 e are other indications, specifically breast cancer staging, in which MRI is being utilized with incr

45 ttee on Cancer/Union International Contre le Cancer staging, kappa = 0.811; Enneking staging, kappa =

46 The American Joint Committee on Cancer staging manual (sixth edition) states that histol

47 into the seventh edition (2009) of the AJCC Cancer Staging Manual and implemented by early 2010.

48 of American Joint Committee on Cancer (AJCC) Cancer Staging Manual for colon cancer subdivided stage

49 publication of the sixth edition of the AJCC Cancer Staging Manual in the year 2002.

50 idal melanomas in the seventh edition of the Cancer Staging Manual of the American Joint Committee on

51 h edition of the American Joint Committee on Cancer staging manual was performed by 2 readers in sepa

52 uidelines is the American Joint Committee on Cancer Staging Manual, 7th edition.

53 hing (18)F-FDG PET/MR imaging for whole-body cancer staging may be challenging because it requires mo

54 cancer (or unknown primary cancer), initial cancer staging, restaging, and suspected cancer recurren

55 sulted in improved hemostasis, more accurate cancer staging, safer and less invasive methods of remov

56 unsuspected pulmonary emboli (PE) on routine cancer staging scans.

57 A preoperative lung cancer staging strategy that includes EBUS-TBNA seems to

58 ican Joint Committee on Cancer (AJCC) rectal cancer staging subdivided stage II into IIA (T3N0) and I

59 FIGO and the actual tests used for cervical cancer staging, suggesting a need to reassess the releva

60 according to the American Joint Committee on Cancer staging system (6th edition) and grouped as stage

61 previously described and validated a breast cancer staging system (CPS+EG, clinical-pathologic scori

62 oration into the American Joint Committee on Cancer staging system and better prediction of survival.

63 A long overdue revision of the breast cancer staging system becomes effective in January 2003,

64 We previously described a novel breast cancer staging system for assessing prognosis after neoa

65 The American Joint Committee on Cancer staging system for breast cancer was recently upd

66 viously defined and validated a novel breast cancer staging system incorporating the American Joint C

67 Our results validate an improved breast cancer staging system that incorporates grade and ER sta

68 hould be incorporated in the pTNM esophageal cancer staging system to better predict patient outcome

69 nsidered for the American Joint Committee on Cancer staging system.

70 into the current American Joint Committee on Cancer staging system.

71 according to the American Joint Committee on Cancer staging system.

72 a modified 1983 American Joint Committee on Cancer staging system.

73 porated into the American Joint Committee on Cancer staging system.

74 The purpose of cancer staging systems is to accurately predict patient

75 arch and patient care, the evaluation of eye cancer staging systems requires international multicente

76 s of diagnosis, American Joint Commission on Cancer staging, treatment, and outcome of patients with

77 ists in different domains including: bladder cancer staging, tumour site of origin and mislabelled ce